Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma

NCT03180268 is registered in ClinicalTrials.gov with NRG Oncology as lead sponsor.

NCT NCT03180268
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03180268 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma
Lead sponsor
NRG Oncology
Phase
Phase 3
Overall status
Active, not recruiting
Start date
September 12, 2017
Completion date
June 15, 2032
Enrollment
162 (actual)
Sites
215

Conditions

As the registry lists them; a condition with its own page is linked.

grade 2 meningioma, intracranial meningioma